FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064237002> ?p ?o ?g. }

• W2064237002 endingPage "336" @default.
• W2064237002 startingPage "328" @default.
• W2064237002 abstract "pT1 G3 bladder carcinomas are heterogeneous with respect to tumor recurrence and progression. Whereas some urologists treat these carcinomas by repeated transurethral resections often followed by intravesical chemotherapy or BCG instillation, others recommend cystectomy after tumor recurrence or early cystectomy after the initial diagnosis. Our goal was to determine the prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak, and Ki-67 immunoreactivity in these tumors. There were 30 patients with a new histopathological diagnosis of pT1 G3 urothelial carcinoma based on a transurethral resection specimen. Representative sections of these specimens were examined for the above markers. All patients were followed up regularly and were classified as being tumor free or having tumor recurrence or progression. The mean follow-up period was 43 months (range: 8-102 months). Twenty-five patients underwent radical cystectomy and 7 of these (28%) suffered from tumor progression and died of bladder cancer. In 5 patients, surgery was limited to a transurethral resection and 4 of these patients developed superficial tumor recurrence. There was a significant difference in tumor-free survival between patients with p53-immunoreactive (mean: 30 months) and p53-negative tumors (mean: 82 months; p = 0.0341). Bcl-2 positivity was also associated with decreased tumor-free survival (p = 0.043). The other markers had no significant prognostic impact. We conclude that p53 and Bcl-2 immunoreactivity labels the most aggressive pT1 G3 bladder carcinomas." @default.
• W2064237002 created "2016-06-24" @default.
• W2064237002 creator A5014396699 @default.
• W2064237002 creator A5014506703 @default.
• W2064237002 creator A5048647967 @default.
• W2064237002 creator A5055087216 @default.
• W2064237002 date "2001-01-01" @default.
• W2064237002 modified "2023-09-26" @default.
• W2064237002 title "Prognostic Value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 Immunoreactivity in pT1 G3 Urothelial Bladder Carcinomas" @default.
• W2064237002 cites W1965727118 @default.
• W2064237002 cites W1973645342 @default.
• W2064237002 cites W1975123036 @default.
• W2064237002 cites W1982107938 @default.
• W2064237002 cites W1985636678 @default.
• W2064237002 cites W1990844560 @default.
• W2064237002 cites W1991613757 @default.
• W2064237002 cites W1993069930 @default.
• W2064237002 cites W2001453283 @default.
• W2064237002 cites W2004259062 @default.
• W2064237002 cites W2005756701 @default.
• W2064237002 cites W2008131891 @default.
• W2064237002 cites W2008782229 @default.
• W2064237002 cites W2012690203 @default.
• W2064237002 cites W2016974966 @default.
• W2064237002 cites W2018823883 @default.
• W2064237002 cites W2028941375 @default.
• W2064237002 cites W2029648806 @default.
• W2064237002 cites W2032051591 @default.
• W2064237002 cites W2032532410 @default.
• W2064237002 cites W2051629716 @default.
• W2064237002 cites W2056699710 @default.
• W2064237002 cites W2057394179 @default.
• W2064237002 cites W2060655552 @default.
• W2064237002 cites W2061563336 @default.
• W2064237002 cites W2061576820 @default.
• W2064237002 cites W2063780681 @default.
• W2064237002 cites W2067062606 @default.
• W2064237002 cites W2079407406 @default.
• W2064237002 cites W2081194991 @default.
• W2064237002 cites W2082410246 @default.
• W2064237002 cites W2084684861 @default.
• W2064237002 cites W2088395263 @default.
• W2064237002 cites W2092113374 @default.
• W2064237002 cites W2093199751 @default.
• W2064237002 cites W2094196477 @default.
• W2064237002 cites W2094668802 @default.
• W2064237002 cites W2107696963 @default.
• W2064237002 cites W2119682635 @default.
• W2064237002 cites W2120293789 @default.
• W2064237002 cites W2146204276 @default.
• W2064237002 cites W2167118789 @default.
• W2064237002 cites W2397932589 @default.
• W2064237002 cites W2405359319 @default.
• W2064237002 cites W2414081795 @default.
• W2064237002 cites W2481787462 @default.
• W2064237002 doi "https://doi.org/10.1159/000050635" @default.
• W2064237002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11553864" @default.
• W2064237002 hasPublicationYear "2001" @default.
• W2064237002 type Work @default.
• W2064237002 sameAs 2064237002 @default.
• W2064237002 citedByCount "38" @default.
• W2064237002 countsByYear W20642370022012 @default.
• W2064237002 countsByYear W20642370022013 @default.
• W2064237002 countsByYear W20642370022014 @default.
• W2064237002 countsByYear W20642370022015 @default.
• W2064237002 countsByYear W20642370022016 @default.
• W2064237002 countsByYear W20642370022017 @default.
• W2064237002 countsByYear W20642370022018 @default.
• W2064237002 countsByYear W20642370022019 @default.
• W2064237002 countsByYear W20642370022022 @default.
• W2064237002 crossrefType "journal-article" @default.
• W2064237002 hasAuthorship W2064237002A5014396699 @default.
• W2064237002 hasAuthorship W2064237002A5014506703 @default.
• W2064237002 hasAuthorship W2064237002A5048647967 @default.
• W2064237002 hasAuthorship W2064237002A5055087216 @default.
• W2064237002 hasConcept C121608353 @default.
• W2064237002 hasConcept C126322002 @default.
• W2064237002 hasConcept C126894567 @default.
• W2064237002 hasConcept C143998085 @default.
• W2064237002 hasConcept C204232928 @default.
• W2064237002 hasConcept C2775910329 @default.
• W2064237002 hasConcept C2776694085 @default.
• W2064237002 hasConcept C2777546739 @default.
• W2064237002 hasConcept C2777661416 @default.
• W2064237002 hasConcept C2779256057 @default.
• W2064237002 hasConcept C2780352672 @default.
• W2064237002 hasConcept C2910508445 @default.
• W2064237002 hasConcept C2992225637 @default.
• W2064237002 hasConcept C3017404179 @default.
• W2064237002 hasConcept C3020813896 @default.
• W2064237002 hasConcept C71924100 @default.
• W2064237002 hasConceptScore W2064237002C121608353 @default.
• W2064237002 hasConceptScore W2064237002C126322002 @default.
• W2064237002 hasConceptScore W2064237002C126894567 @default.
• W2064237002 hasConceptScore W2064237002C143998085 @default.
• W2064237002 hasConceptScore W2064237002C204232928 @default.
• W2064237002 hasConceptScore W2064237002C2775910329 @default.
• W2064237002 hasConceptScore W2064237002C2776694085 @default.

• next